Sex Differences in Cognitive Abilities Among Children With the Autosomal Dominant Alzheimer Disease Presenilin 1 E280A Variant From a Colombian Cohort

Authors:

Abstract
Individuals with autosomal dominant Alzheimer Disease (ADAD) variants develop early onset Alzheimer disease (AD) with nearly 100% penetrance, providing a unique opportunity to characterize the earliest biological and cognitive changes associated with the disease.1 Biomarker investigations of families with ADAD variants have revealed AD-related brain changes prior to the onset of clinical symptoms.2 We previously reported that children with the presenilin 1 (PSEN1) E280A ADAD variant, compared with child-aged family members without this variant, exhibited plasma biomarker levels consistent with early life amyloid β overproduction, as well as increased gray matter volume in temporal regions and decreased functional magnetic resonance imaging deactivation of posterior parietal regions during a memory encoding task.3 These AD-related biomarker differences were seen approximately 3 decades before the median age of onset of mild cognitive impairment (MCI) in individuals with the PSEN1 E280A variant.2 We also recently reported that women with the PSEN1 E280A variant who were not cognitively impaired had better verbal episodic memory performance compared with men with the variant who were not impaired,4 consistent with research that has found greater performance on verbal memory tests among healthy older women compared with healthy older men5 (although women with MCI or dementia may have more precipitous cognitive decline compared with men with cognitive impairment6). To our knowledge, however, no study has investigated the cognitive performance of children with ADAD variants compared with those without variants, nor the possible sex differences in cognitive performance in childhood in this population.

This publication has 21 references indexed in Scilit: